K W Kohn1, J Jackman, P M O'Connor
1Laboratory of Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Cancer therapies may improve by targeting cell cycle regulation defects. Understanding how oncogenes and tumor suppressor genes impact cell cycle control offers new avenues for personalized cancer treatments.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: